Patent Evaluation Central & Peripheral Nervous Systems: 5-HT1A agonists: Expert Opinion on Therapeutic Patents: Vol 6, No 10

Views

CrossRef citations to date

Altmetric

Abstract

Hexahydropyrazinoquinoline derivatives are claimed, along with procedures for their preparation, compositions of 5-HT_1A receptor agonists containing the compounds and methods for treating CNS disorders using them. The compounds are stated to have affinity for 5-HT_1A receptors and are claimed to be useful for the prevention and treatment of:

Key Words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Patent Evaluation Central & Peripheral Nervous Systems: 5-HT₁A agonists

Information for

Open access

Opportunities

Help and information

Patent Evaluation Central & Peripheral Nervous Systems: 5-HT1A agonists

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature

Patent Evaluation Central & Peripheral Nervous Systems: 5-HT₁A agonists